OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma NSCLC patients with EGFR mutation

HTML

Year: 2012
Type: article
Study design: Observational Study
Source: Cancer Chemotherapy and Pharmacology
DOI: 10.1007/s00280-012-1876-0
Authors: Su-Hee Cho, Lee Chun Park, Jun Ho Ji, Silvia Park, Deok Won Hwang, Ji Yean Lee, Yoon-La Choi, Jung-Ho Han, Jong-Mu Sun, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
Institutions: Samsung Medical Center, Sungkyunkwan University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR tyrosine kinase inhibitors, gefitinib, erlotinib, non-small cell lung cancer, EGFR mutation, exon 19 deletion, progression-free survival, overall survival, response rate, Korean patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2017128352
FWCI: 1.225
Cites: 22
Cited by: 22
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security